Health
Common diabetes drug can reduce risk of major heart issues – TheHealthSite
SGLT2 inhibitors prescribed for diabetes can reduce the risk of heart conditions such as heart attack stroke and heart failure compared with placebo.
Drugs known as sodium-glucose cotransporter 2 (SGLT2) inhibitors are associated with a lower risk of major heart problems in patients with type 2 diabetes than dipeptidyl peptidase-4 (DPP-4) inhibitors, say, researchers. According to the study, published in the journal The BMJ, previous trials have shown that SGLT2 inhibitors can reduce the risk of heart conditions such as heart attack, stroke, and heart failure compared with placebo. But some of these trials had important limitations, making it…
-
Noosa News22 hours agoThe Laundry Lady secures $1M to fuel international expansion
-
Noosa News19 hours agoTruffle growers say rare delicacy is worth its $3,500 per kilo expense
-
Noosa News12 hours agoWhere, when and why? Everything you need to know about Sunday’s pro-Palestine protest march in Brisbane
-
Noosa News19 hours agoHomicide investigation underway after woman found dead in north Brisbane